That gap is often the difference between fast progress and a plateau
Especially tell your healthcare provider if you take: Any medications that are affected by antioxidants
Future of GLP-1 Medications: In Development: Oral formulations (Rybelsus exists but less effective) Monthly injection versions Triple agonist medications (GIP/GLP-1/glucagon) Combinations with other weight loss mechanisms The GLP-1 class will likely dominate weight loss treatment for the next decade while continuing to improve
We share an ancestor with the Galpagos tortoise, with the Greenland shark
Animal studies suggest it may support bone healing after fractures as well as muscle repair
Novo plans to begin selling its FDA-approved weight-loss pill in the US in January following Oasis 4 trial results showing 13.6% average weight loss over 64 weeks, while Lilly's oral alternative, orforglipron, received expedited FDA review under a new 2025 voucher program and could be approved as soon as March, according to CEO Dave Ricks